T. Rowe Price Associates’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.41B | Buy |
|
|||||
|
2025
Q1 | $1.41B | Buy |
|
|||||
|
2024
Q4 | $681M | Sell |
|
|||||
|
2024
Q3 | $822M | Sell |
|
|||||
|
2024
Q2 | $1.04B | Sell |
|
|||||
|
2024
Q1 | $1.88B | Sell |
|
|||||
|
2023
Q4 | $2.4B | Sell |
|
|||||
|
2023
Q3 | $2.38B | Buy |
|
|||||
|
2023
Q2 | $2.38B | Buy |
|
|||||
|
2023
Q1 | $2.08B | Buy |
|
|||||
|
2022
Q4 | $1.36B | Sell |
|
|||||
|
2022
Q3 | $1.49B | Buy |
|
|||||
|
2022
Q2 | $1.4B | Sell |
|
|||||
|
2022
Q1 | $1.38B | Sell |
|
|||||
|
2021
Q4 | $1.19B | Sell |
|
|||||
|
2021
Q3 | $1.03B | Sell |
|
|||||
|
2021
Q2 | $2.64B | Sell |
|
|||||
|
2021
Q1 | $3.56B | Sell |
|
|||||
|
2020
Q4 | $4.63B | Sell |
|
|||||
|
2020
Q3 | $5.54B | Sell |
|
|||||
|
2020
Q2 | $6.15B | Sell |
|
|||||
|
2020
Q1 | $5.15B | Sell |
|
|||||
|
2019
Q4 | $5.37B | Sell |
|
|||||
|
2019
Q3 | $4.45B | Buy |
|
|||||
|
2019
Q2 | $4.56B | Sell |
|
|||||
|
2019
Q1 | $4.81B | Buy |
|
|||||
|
2018
Q4 | $4.27B | Buy |
|
|||||
|
2018
Q3 | $4.83B | Sell |
|
|||||
|
2018
Q2 | $4.36B | Sell |
|
|||||
|
2018
Q1 | $4.49B | Sell |
|
|||||
|
2017
Q4 | $4.25B | Buy |
|
|||||
|
2017
Q3 | $4.03B | Buy |
|
|||||
|
2017
Q2 | $3.17B | Buy |
|
|||||
|
2017
Q1 | $2.51B | Buy |
|
|||||
|
2016
Q4 | $1.61B | Sell |
|
|||||
|
2016
Q3 | $2.05B | Buy |
|
|||||
|
2016
Q2 | $2B | Sell |
|
|||||
|
2016
Q1 | $1.99B | Buy |
|
|||||
|
2015
Q4 | $2.37B | Buy |
|
|||||
|
2015
Q3 | $1.56B | Buy |
|
|||||
|
2015
Q2 | $1.66B | Sell |
|
|||||
|
2015
Q1 | $1.59B | Buy |
|
|||||
|
2014
Q4 | $1.58B | Sell |
|
|||||
|
2014
Q3 | $1.59B | Buy |
|
|||||
|
2014
Q2 | $1.31B | Buy |
|
|||||
|
2014
Q1 | $836M | Buy |
|
|||||
|
2013
Q4 | $695M | Buy |
|
|||||
|
2013
Q3 | $523M | Buy |
|
|||||
|
2013
Q2 | $526M | Buy |
|